LYFIX vs. IBB
LYFIX (AlphaCentric LifeSci Healthcare Fund) and IBB (iShares Nasdaq Biotechnology ETF) are both Health & Biotech Equities funds. Over the past 5 years, LYFIX returned 6.33%/yr vs 2.21%/yr for IBB. Their correlation of 0.83 suggests significant overlap in exposure. LYFIX charges 1.40%/yr vs 0.47%/yr for IBB.
Performance
LYFIX vs. IBB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LYFIX achieves a 9.31% return, which is significantly higher than IBB's 5.61% return.
LYFIX
- 1D
- 3.21%
- 1M
- 6.36%
- YTD
- 9.31%
- 6M
- 8.56%
- 1Y
- 46.30%
- 3Y*
- 10.63%
- 5Y*
- 6.33%
- 10Y*
- —
IBB
- 1D
- 0.62%
- 1M
- 5.52%
- YTD
- 5.61%
- 6M
- 3.57%
- 1Y
- 42.90%
- 3Y*
- 11.80%
- 5Y*
- 2.21%
- 10Y*
- 8.21%
LYFIX vs. IBB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
LYFIX AlphaCentric LifeSci Healthcare Fund | 9.31% | 28.22% | -0.27% | 7.19% | -0.92% | -3.42% | 54.83% | 1.20% |
IBB iShares Nasdaq Biotechnology ETF | 5.61% | 27.98% | -2.41% | 3.76% | -13.69% | 0.95% | 26.01% | 1.04% |
Correlation
The correlation between LYFIX and IBB is 0.92, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.92 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.86 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.84 |
Correlation (All Time) Calculated using the full available price history since Nov 29, 2019 | 0.83 |
The correlation between LYFIX and IBB has been stable across timeframes, ranging from 0.83 to 0.92 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LYFIX vs. IBB — Risk / Return Rank
LYFIX
IBB
LYFIX vs. IBB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AlphaCentric LifeSci Healthcare Fund (LYFIX) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LYFIX | IBB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.38 | ||
| Sortino ratioReturn per unit of downside risk | +0.47 | ||
| Omega ratioGain probability vs. loss probability | 1.41 | 1.35 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 5.58 | 4.47 | +1.11 |
| Martin ratioReturn relative to average drawdown | 20.30 | 13.77 | +6.53 |
Loading charts...
Drawdowns
LYFIX vs. IBB - Drawdown Comparison
The maximum LYFIX drawdown since its inception was -35.33%, smaller than the maximum IBB drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for LYFIX and IBB.
Loading charts...
Drawdown Indicators
| LYFIX | IBB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.33% | -62.85% | +27.52% |
Max Drawdown (1Y)Largest decline over 1 year | -8.49% | -9.63% | +1.14% |
Max Drawdown (3Y)Largest decline over 3 years | -24.22% | -24.85% | +0.63% |
Max Drawdown (5Y)Largest decline over 5 years | -32.21% | -39.82% | +7.61% |
Max Drawdown (10Y)Largest decline over 10 years | — | -39.82% | — |
Current DrawdownCurrent decline from peak | 0.00% | 0.00% | 0.00% |
Average DrawdownAverage peak-to-trough decline | -9.79% | -21.14% | +11.35% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.33% | 3.12% | -0.79% |
Volatility
LYFIX vs. IBB - Volatility Comparison
AlphaCentric LifeSci Healthcare Fund (LYFIX) has a higher volatility of 7.42% compared to iShares Nasdaq Biotechnology ETF (IBB) at 6.95%. This indicates that LYFIX's price experiences larger fluctuations and is considered to be riskier than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LYFIX | IBB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.42% | 6.95% | +0.47% |
Volatility (6M)Calculated over the trailing 6-month period | 15.27% | 15.98% | -0.71% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.97% | 20.34% | -1.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.95% | 22.03% | +0.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.44% | 23.17% | +0.27% |
LYFIX vs. IBB - Expense Ratio Comparison
LYFIX has a 1.40% expense ratio, which is higher than IBB's 0.47% expense ratio.
Dividends
LYFIX vs. IBB - Dividend Comparison
LYFIX's dividend yield for the trailing twelve months is around 1.63%, more than IBB's 0.23% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology ETF | 0.23% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
LYFIX AlphaCentric LifeSci Healthcare Fund | 1.63% | 1.78% | 2.24% | 2.63% | 4.43% | 12.88% | 2.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
With a correlation of 0.92, LYFIX and IBB move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
LYFIX has higher volatility (7.42%) compared to IBB (6.95%). In terms of maximum drawdown, LYFIX dropped -35.33% vs IBB's -62.85%.
LYFIX currently has the higher Sharpe Ratio (2.50 vs 2.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LYFIX and IBB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer